Engineered Cas9 nucleases
US12297466B2 · kind B2 · utility
0Cited by
88References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2021 |
| Grant date | May 13, 2025 |
| Priority date | — |
| Expiry date | Jul 14, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/80
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure relates to Cas9 nuclease variants and methods of producing and using such variants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.